IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer
US8110370B2 · kind B2 · utility
0Cited by
2References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2009 |
| Grant date | Feb 7, 2012 |
| Priority date | — |
| Expiry date | Oct 2, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/25
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This invention encompasses antibodies specific for IBC-1 (Invasive Breast Cancer-1), methods for diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions, methods of identifying and manufacturing therapeutic compounds, and methods of treating patients with invasive and metastatic breast cancer or degenerative neural conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.